SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 433.83 |
| Enterprise Value ($M) | 283.69 |
| Book Value ($M) | 170.78 |
| Book Value / Share | 13.27 |
| Price / Book | 2.54 |
| NCAV ($M) | 149.57 |
| NCAV / Share | 11.63 |
| Price / NCAV | 2.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.38 |
| Return on Equity (ROE) | -0.42 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.74 |
| Current Ratio | 14.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 174.14 |
| Assets | 195.35 |
| Liabilities | 24.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -55.58 |
| Net Income | -36.32 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -51.42 |
| Cash from Investing | 25.64 |
| Cash from Financing | 92.48 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Janus Henderson Group Plc | 6.60 | ||
| 13G | Cormorant Asset Management, LP | 5.82 | ||
| 13G/A | Redmile Group, LLC | |||
| 13G | Samsara BioCapital, L.P. | 9.99 | ||
| 13G/A | Great Point Partners Llc | 7.75 | 2.58 | |
| 13G | EcoR1 Capital, LLC | 9.99 | ||
| 13D | McMinn Rachel | 9.90 | ||
| 13D/A | Baker Bros. Advisors Lp | 4.99 | -93.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 7,635 | 44,455 | 17.17 | |
| 10,616 | 53,885 | 19.70 | |
| 6,642 | 51,187 | 12.98 | |
| 11,428 | 82,957 | 13.78 | |
| 5,037 | 47,541 | 10.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MURA – Mural Oncology plc | NAII – Natural Alternatives International, Inc. |
| NAMS – NewAmsterdam Pharma Company N.V. | NKGN – NKGen Biotech, Inc. |
| NRIX – Nurix Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io